Cargando…
Evidence-based capacity of natural cytochrome enzyme inhibitors to increase the effectivity of antineoplastic drugs
ABSTRACT: Cytochrome (CYP) enzymes catalyze the metabolism of numerous exogenous and endogenous substrates in cancer therapy leading to significant drug interactions due to their metabolizing effect. CYP enzymes play an important role in the metabolism of essential anticancer medications. They are s...
Autores principales: | Manthalkar, Laxmi, Ajazuddin, Bhattacharya, Sankha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792636/ https://www.ncbi.nlm.nih.gov/pubmed/36571647 http://dx.doi.org/10.1007/s12672-022-00605-y |
Ejemplares similares
-
Resistance to antineoplastic drugs
por: Twentyman, Peter
Publicado: (1990) -
PARP1 in Carcinomas and PARP1 Inhibitors as Antineoplastic Drugs
por: Wang, Luyao, et al.
Publicado: (2017) -
Pharmacological Applications of Nrf2 Inhibitors as Potential Antineoplastic Drugs
por: Telkoparan-Akillilar, Pelin, et al.
Publicado: (2019) -
The support of genetic evidence for cardiovascular risk induced by antineoplastic drugs
por: Cui, Hui, et al.
Publicado: (2020) -
Arsenic-Based Antineoplastic Drugs and Their Mechanisms of Action
por: Ralph, Stephen John
Publicado: (2008)